Biotechnology is next big thing with investors

BIOTECH BOOM: There are six bio-tech parks in India and 19 more are in the pipeline.

Other stories in the section:

Beggars also feel the inflation pinch!

Life for scores of beggars at the city's traffic intersections is no longer good.

• Inflation up at 11.63 per cent

Featured Blog

Abhishek Patni

MAULANA MULAYAM AND PERILS OF NUCLEAR DEAL

Featured Slideshows

New Delhi: Biotechnology could be the next big driver of commercial real estate prices. It's expected to need 80 to 100 million square feet by 2010.

Investment in such factories has been growing fast. In 2003, Rs 14 crore was invested and in 2006, the figure more than doubled to Rs 36 crore. The biotech sector has grown 33 per cent since last year.

It’s revenues total $2 billion but by 2010, revenues will reach $5billion, says a report from property consultant Jones Lang Lasalle Meghraj JLLM.

It says international firms like Glaxo Smithkline and Pfizer are investing in the industry, which will boost real-estate demand.

"India is no longer relying purely on the IT sector to grow the real estate industry. The access to the talent pool, the infrastructure and the costs of the labour and equally the costs of components; it has a big impact on their decision to come into India,” said CEO of JLLM, Vincent Lottefier.

Although Mumbai has traditionally been the preferred choice of location, companies are focusing on cities where land prices are more reasonable.

In Hyderabad, for instance, land values in some areas jumped 30 to 40 per cent after ICICI Knowledge Park and Shapoorji Pallonji Biotech Park came up there.

Other popular destinations include Bangalore, Pune and the National Capital Region. The report says various incentives such as 100 per cent foreign equity investment, customs duty exemption, and 100 per cent tax rebate on resource and development expenditure, offered by the government have made this sector attractive.

So, investors are flocking to the sector. There are six bio-tech parks in India and 19 more are in the pipeline.

(With inputs from Rohini Singh)